A key enzyme and its molecular pathway are critical to keeping certain immune cells active and away from "exhaustion," ...

A Phase I trial involving ten patients with relapsed or refractory classical Hodgkin lymphoma or T-cell lymphoma has achieved ...

In a Phase 1 clinical trial, a CAR T-cell therapy targeting the CD30 protein has been shown to promote the expansion of ...

New types of T cells seem to pop up in the scientific literature with increasing frequency. Just this June, for instance, University of Melbourne immunologist Angela Pizzolla and her colleagues ...

While this review was in press, it has been shown by Kivisäkk and colleagues 121 that human central memory CD4 + T cells traffic into the CSF across either the choroid plexus or the meningeal ...

In a phase I trial involving ten patients with relapsed or refractory classical Hodgkin lymphoma or T-cell lymphoma, a 100% overall response rate and a 50% complete remission rate were achieved, along ...